A Cross-sectional study of Challenges Faced by Under-Resourced Women with Substance Use Disorders during the COVID-19 Pandemic: Implications for Treatment and Care Delivery

Author:

Mejia M. Carmenza1,Kowalchuk Alicia1,Gonzalez Sandra1,Webb Lisa1,Nair Muktha1,Scamp Nadine2

Affiliation:

1. Baylor College of Medicine

2. Santa Maria Hostel, Inc Houston

Abstract

Abstract Background: The COVID-19 pandemic has exacerbated existing disparities in access to mental health care and treatment for substance use disorders (SUD), particularly in under-resourced communities. This study aimed to understand the experiences of under-resourced women with substance use disorders during the COVID-19 pandemic, their knowledge and attitudes towards the pandemic, and its impact on their substance use and access to treatment. Methods: This is a cross-sectional study of 66 under-resourced women receiving medically managed withdrawal treatment in a community residential SUD treatment center. Data were collected from November 2021 to August 2022 through a 75-item instrument covering topics related to COVID-19 exposure, pandemic impact on health, substance use, and access to treatment, COVID-19 vaccination status and attitudes, as well as knowledge and beliefs about the virus and pandemic risk mitigation measures. Descriptive analyses were conducted to summarize the data. Results: Results revealed that participants faced numerous challenges during the pandemic. Many reported increased substance use, particularly alcohol, opioids, benzodiazepines, and nicotine. Mental health stability was also negatively impacted, with a majority reporting the exacerbation of existing mental health disorders and difficulties accessing mental health care. Job loss, housing instability, and financial strain were prevalent among the participants. Half of the respondents received at least one dose of a COVID-19 vaccine, while 27.3% did not receive the COVID-19 vaccine and were not considering it. Vaccine hesitancy was observed due to concerns about lack of knowledge and religious beliefs. The majority (62.1%) of participants felt that their greatest worry was about challenges to securing basic needs such as groceries or medication, and (64.6%) reported a desire to cope using alcohol or drugs. Conclusions: These findings highlight the need for gender-responsive and culturally appropriate approaches to substance use disorders treatment. Additionally, efforts should focus on improving access to mental health care, reducing stigma, and providing resources and support to individuals with co-occurring mental health conditions during and after the pandemic. This study provides valuable insights to refine substance use care delivery and recovery services for under-resourced women, both in the early post-pandemic period and in preparation for future global crises.

Publisher

Research Square Platform LLC

Reference32 articles.

1. Innovation During COVID-19: Improving Addiction Treatment Access;Samuels EA;J Addict Med,2020

2. Psychiatry and COVID-19;Öngür D;JAMA,2020

3. SAMHSA, Disaster Technical Assistance Center. Supplemental Research Bulletin A Preliminary Look at the Mental Health and Substance Use-related Effects of the COVID-19 Pandemic.. 2021.

4. Mental Health Disorders Related to COVID-19-Related Deaths;Simon NM;JAMA,2020

5. HC P. & US HHS., Health Canada, Public Health Agency of Canada, and U.S. Department of Health and Human Services. Canada-U.S. Joint White Paper: Substance Use and Harms During COVID-19 and Approaches to Federal Surveillance and Response. Ottawa, Ontario; Washington, D.C.: U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, 2022. 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3